287 related articles for article (PubMed ID: 29923765)
21. Ambient fine particulate matter aggravates atherosclerosis in apolipoprotein E knockout mice by iron overload via the hepcidin-ferroportin axis.
Wan Q; Yang M; Liu Z; Wu J
Life Sci; 2021 Jan; 264():118715. PubMed ID: 33160991
[TBL] [Abstract][Full Text] [Related]
22. Iron- and Hepcidin-Independent Downregulation of the Iron Exporter Ferroportin in Macrophages during
Willemetz A; Beatty S; Richer E; Rubio A; Auriac A; Milkereit RJ; Thibaudeau O; Vaulont S; Malo D; Canonne-Hergaux F
Front Immunol; 2017; 8():498. PubMed ID: 28507548
[TBL] [Abstract][Full Text] [Related]
23. Physiological focus on the erythropoietin-hepcidin-ferroportin axis.
D'Anna MC; Roque ME
Can J Physiol Pharmacol; 2013 May; 91(5):338-45. PubMed ID: 23656253
[TBL] [Abstract][Full Text] [Related]
24. The role of cellular iron deficiency in controlling iron export.
Link C; Knopf JD; Marques O; Lemberg MK; Muckenthaler MU
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129829. PubMed ID: 33340587
[TBL] [Abstract][Full Text] [Related]
25. Fetal liver hepcidin secures iron stores in utero.
Kämmerer L; Mohammad G; Wolna M; Robbins PA; Lakhal-Littleton S
Blood; 2020 Sep; 136(13):1549-1557. PubMed ID: 32542311
[TBL] [Abstract][Full Text] [Related]
26. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.
Rishi G; Secondes ES; Wallace DF; Subramaniam VN
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32301493
[TBL] [Abstract][Full Text] [Related]
27. The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload.
Mohammad G; Matakidou A; Robbins PA; Lakhal-Littleton S
Kidney Int; 2021 Sep; 100(3):559-569. PubMed ID: 33991530
[TBL] [Abstract][Full Text] [Related]
28. Disruption of the hepcidin/ferroportin regulatory circuitry causes low axial bone mass in mice.
Ledesma-Colunga MG; Baschant U; Fiedler IAK; Busse B; Hofbauer LC; Muckenthaler MU; Altamura S; Rauner M
Bone; 2020 Aug; 137():115400. PubMed ID: 32380257
[TBL] [Abstract][Full Text] [Related]
29. Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
Ganz T; Nemeth E
Semin Nephrol; 2016 Mar; 36(2):87-93. PubMed ID: 27236128
[TBL] [Abstract][Full Text] [Related]
30. Ferroportin-1 is a 'nuclear'-negative acute-phase protein in rat liver: a comparison with other iron-transport proteins.
Naz N; Malik IA; Sheikh N; Ahmad S; Khan S; Blaschke M; Schultze F; Ramadori G
Lab Invest; 2012 Jun; 92(6):842-56. PubMed ID: 22469696
[TBL] [Abstract][Full Text] [Related]
31. Change in iron metabolism in rats after renal ischemia/reperfusion injury.
Xie GL; Zhu L; Zhang YM; Zhang QN; Yu Q
PLoS One; 2017; 12(4):e0175945. PubMed ID: 28426710
[TBL] [Abstract][Full Text] [Related]
32. Obesity promotes alterations in iron recycling.
Citelli M; Fonte-Faria T; Nascimento-Silva V; Renovato-Martins M; Silva R; Luna AS; Silva SV; Barja-Fidalgo C
Nutrients; 2015 Jan; 7(1):335-48. PubMed ID: 25569627
[TBL] [Abstract][Full Text] [Related]
33. Normal systemic iron homeostasis in mice with macrophage-specific deletion of transferrin receptor 2.
Rishi G; Secondes ES; Wallace DF; Subramaniam VN
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G171-80. PubMed ID: 26608187
[TBL] [Abstract][Full Text] [Related]
34. Immunolocalization of ferroportin in healthy and anemic mice.
D'Anna MC; Veuthey TV; Roque ME
J Histochem Cytochem; 2009 Jan; 57(1):9-16. PubMed ID: 18796409
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of the functional properties of human and mouse ferroportin.
Azucenas CR; Ruwe TA; Bonamer JP; Qiao B; Ganz T; Jormakka M; Nemeth E; Mackenzie B
Am J Physiol Cell Physiol; 2023 May; 324(5):C1110-C1118. PubMed ID: 36939203
[TBL] [Abstract][Full Text] [Related]
36. Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice.
Chiabrando D; Fiorito V; Marro S; Silengo L; Altruda F; Tolosano E
Blood Cells Mol Dis; 2013 Jan; 50(1):25-30. PubMed ID: 22921471
[TBL] [Abstract][Full Text] [Related]
37. Copper deficiency has minimal impact on ferroportin expression or function.
Prohaska JR; Broderius M
Biometals; 2012 Aug; 25(4):633-42. PubMed ID: 22294464
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
39. Iron metabolism in hepcidin1 knockout mice in response to phenylhydrazine-induced hemolysis.
Masaratana P; Latunde-Dada GO; Patel N; Simpson RJ; Vaulont S; McKie AT
Blood Cells Mol Dis; 2012 Aug; 49(2):85-91. PubMed ID: 22609087
[TBL] [Abstract][Full Text] [Related]
40. Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload.
Altamura S; Kessler R; Gröne HJ; Gretz N; Hentze MW; Galy B; Muckenthaler MU
Cell Metab; 2014 Aug; 20(2):359-67. PubMed ID: 25100063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
